We are live on ! Find out more
GT

Glenmede Trust Portfolio holdings

AUM $20.4B
This Fund
S&P 500
This Quarter Est. Return
+8.99%
1 Year Est. Return
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$21.9B
AUM Growth
+$21.9B
Cap. Flow
-$417M
Cap. Flow %
-1.9%
Top 10 Hldgs %
13.08%
Holding
3,337
New
135
Increased
1,103
Reduced
1,007
Closed
163

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$89.3M
2
KEYS icon
Keysight
KEYS
+$86M
3
NKE icon
Nike
NKE
+$78.3M
4
APH icon
Amphenol
APH
+$76.5M
5
CMCSA icon
Comcast
CMCSA
+$72.3M

Top Sells

Rank Stock Value
1
CE icon
Celanese
CE
+$108M
2
MNST icon
Monster Beverage
MNST
+$97.8M
3
SBUX icon
Starbucks
SBUX
+$79.7M
4
TXN icon
Texas Instruments
TXN
+$67.3M
5
CNC icon
Centene
CNC
+$64.3M

Sector Composition

Rank Sector Weight
1 Technology 18.83%
2 Financials 13.42%
3 Healthcare 13.25%
4 Industrials 9.77%
5 Consumer Discretionary 7.14%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KELYA icon
1951
Kelly Services Class A
KELYA
$560M
$11K ﹤0.01%
488
+138
+39% +$3.11K
KRG icon
1952
Kite Realty
KRG
$5.91B
$11K ﹤0.01%
590
+248
+73% +$4.47K
MSTR icon
1953
Strategy Inc
MSTR
$35.1B
$11K ﹤0.01%
780
+260
+50% +$3.87K
OPI
1954
DELISTED
Office Properties Income Trust
OPI
$11K ﹤0.01%
372
+139
+60% +$4.45K
PLCE icon
1955
Children's Place
PLCE
$55.8M
$11K ﹤0.01%
192
+63
+49% +$4.59K
REG icon
1956
Regency Centers
REG
$14.8B
$11K ﹤0.01%
178
+94
+112% +$6.17K
SCI icon
1957
Service Corp International
SCI
$11.7B
$11K ﹤0.01%
240
-4,528
-95% -$204K
SM icon
1958
SM Energy
SM
$7.11B
$11K ﹤0.01%
1,042
+486
+87% +$4.38K
SUZ icon
1959
Suzano
SUZ
$10.4B
$11K ﹤0.01%
1,142
TVTX icon
1960
Travere Therapeutics
TVTX
$5.2B
$11K ﹤0.01%
815
+721
+767% +$9.21K
USNA icon
1961
Usana Health Sciences
USNA
$429M
$11K ﹤0.01%
149
+38
+34% +$2.8K
PFC
1962
DELISTED
Premier Financial Corp. Common Stock
PFC
$11K ﹤0.01%
389
ROIC
1963
DELISTED
Retail Opportunity Investments Corp.
ROIC
$11K ﹤0.01%
624
+207
+50% +$3.75K
BIG
1964
DELISTED
Big Lots, Inc.
BIG
$11K ﹤0.01%
384
+147
+62% +$3.39K
MDRX
1965
DELISTED
Veradigm Inc. Common Stock
MDRX
$11K ﹤0.01%
1,191
+884
+288% +$9.31K
GCP
1966
DELISTED
GCP Applied Technologies Inc.
GCP
$11K ﹤0.01%
515
+172
+50% +$3.7K
MTOR
1967
DELISTED
MERITOR, Inc.
MTOR
$11K ﹤0.01%
467
EBSB
1968
DELISTED
Meridian Bancorp, Inc.
EBSB
$11K ﹤0.01%
571
CBL
1969
DELISTED
CBL& Associates Properties, Inc.
CBL
$11K ﹤0.01%
10,495
CPL
1970
DELISTED
CPFL Energia S.A.
CPL
$11K ﹤0.01%
656
SMI
1971
DELISTED
Semiconductor Manufacturing Intl
SMI
$11K ﹤0.01%
1,470
ALKS icon
1972
Alkermes
ALKS
$8.42B
$10K ﹤0.01%
497
AVNT icon
1973
Avient
AVNT
$3.41B
$10K ﹤0.01%
315
-57,152
-99% -$1.87M
AZZ icon
1974
AZZ Inc
AZZ
$4.41B
$10K ﹤0.01%
219
+106
+94% +$4.33K
CABO icon
1975
Cable One
CABO
$249M
$10K ﹤0.01%
7
+5
+250% +$7.09K

Similar funds

Glenmede Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Glenmede Trust held 3,337 positions worth $21.9B, up 100,205% from $21.9M the previous quarter. Its ten largest holdings account for 13% of the portfolio.

Glenmede Trust's Q4 2019 filing shows 135 new, 1,103 increased, 1,007 reduced and 163 closed positions. Its largest new stake was Callon Petroleum Company: 285,674 shares worth $13.8M. The largest sale was Celanese, an estimated $108M.

By sector, the portfolio is most concentrated in Technology at 19% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Glenmede Trust's largest Q4 2019 buy was Callon Petroleum Company: 285,674 shares worth $13.8M.
  • Glenmede Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $89.3M increase.
  • Glenmede Trust's biggest Q4 2019 reduction was Celanese, cutting an estimated $108M.
  • Glenmede Trust fully exited Celgene Corp in Q4 2019, selling an estimated $122K.
  • Glenmede Trust's ten largest holdings make up 13% of its $21.9B portfolio in Q4 2019.
  • Glenmede Trust opened 135 new positions and closed 163 in Q4 2019.
  • Glenmede Trust's portfolio value rose 100,205% quarter-over-quarter to $21.9B.

Based on Glenmede Trust's 13F filing for Q4 2019, filed 12 Feb 2020.